RESPIRATORY VIRUSES RESEARCH

新出现/再出现的以及引起疾病的相关呼吸道病毒，如SARS、流感和中东呼吸综合征冠状病毒，由于其高发病率和快速地理传播的潜力，特别令人关注。这一目标有助于更好地了解疾病和治疗方案，并改善受新出现和再出现的呼吸道病毒及相关呼吸道病毒折磨的患者的医疗结果。国家过敏和传染病研究所(NIAID) /临床研究部（DCR）预计将开展支持性研究，这些研究将描述流感、流感样疾病和其他呼吸道疾病在几个不同地理区域和资源环境中的自然历史特征，并使用可快速调整的模型和方法涵盖不同的疾病严重程度。NIAID预计，为了支持研究的开展，Leidos Biomedical将：

Emerging/re-emerging and related respiratory viruses causing disease, such as SARS, influenza, and MERS-CoV, are of particular concern given their significant morbidity and potential for rapid geographic spread. This objective supports the overall goal to better understand the diseases and therapeutic options and to improve medical outcomes for patients afflicted with the emerging and re-emerging and related respiratory viruses. The National Institute of Allergy and Infectious Diseases (NIAID) / Division of Clinical Research (DCR) anticipates supporting studies that will characterize the natural history of influenza, influenza-like-illness, and other respiratory diseases across several different geographic areas and resource settings, and encompass different severities of disease using models and methodologies that can be adapted rapidly. NIAID anticipates that in order to support conduct of the studies, Leidos Biomedical will: 1. Provide scientific, clinical, and technical leadership 2. Procure all materials and supplies necessary to complete the protocols 3. Be responsible for program/project management in the areas of: a. Clinical research management b. Data management c. Biostatistical analysis and reporting.